Facebook
Twitter
LinkedIn
ForwardADA 2020 Symposium - 21st Century Strategies To Reduce Hypoglycemia Risk With Insulin Therapy (RP2006A)
Twenty-First Century Strategies To Reduce Hypoglycemia Risk With Insulin Therapy:
Novel Formulations, New Treatment Combinations, and Next-Generation Delivery Systems
This symposium will provide a comprehensive and current update on strategies to prevent hypoglycemia in patients with diabetes receiving insulin therapy. Concerns specific to patients with both T1DM and T2DM will be addressed, with content focused on the needs of patients in Latin America and individuals of Hispanic/Latino descent. The glycemic benefits of new, ultra-long-acting basal formulations, such as insulin degludec and glargine U-300, will be discussed in context with other, established insulins. Attendees will also learn about the physiologic benefits of adding glucagon-like-peptide-1 receptor agonists (GLP-1 RAs) to basal insulin therapy in patients with T2DM. Attendees will also learn when prandial insulin is the best choice and which analogs offers better safety. An update on contemporary diabetes management technology will be provided; this will include recent regional research evaluating insulin pump therapy in patients with T1DM, as well as strategies to identify and train appropriate patient candidates for pump therapy and the advantages of using newer faster acting insulin analogs. Last, issues specific to specific populations (children, older patients) will be addressed.
CLICK HERE FOR WEBINAR AGENDA
Target Audience
Physicians (Primary Care, Internal Medicine, Endocrinologists), Physician Assistants, Nurse Practitioners, Nurses, and Clinical Diabetes Educators
Learning Objectives
After completing this symposium, physicians and other clinicians will the able to:
- Comprehend the growing epidemic of T2DM throughout Latin America and the United States, which is already causing extreme deleterious effects in the region that if left unabated will lead to considerable morbidity and mortality.
- Discuss the hypoglycemic benefits of novel and established basal and prandial insulin formulations in patients with T1DM and T2DM, and of new, non-insulin injectable therapies (GLP-1 RAs) in patients with T2DM.
- Explain the role of insulin pump therapy in T1DM management and the impact of insulin pump therapy on patient hypoglycemia rates based on recent clinical trials.
- Select appropriate patient candidates for insulin pump treatment.
- Determine best strategies to optimally manage children/adolescents and older adults with T1DM.
Jaime A. Davidson, MD, FACP, MACE (Course Director)
Clinical Professor of Medicine
Touchstone Diabetes Center
UT Southwestern Medical Center
Dallas, Texas, USA
Roque Cardona-Hernandez, MD
Pediatric Endocrinologist
Diabetes Program Director
Hospital Sant Joan de Déu
Barcelona, Spain
Yulino Castillo Núñez, MD
Chair, Endocrinology Department
Coordinator, National Postgraduate Course in Endocrinology and Nutrition
Hospital Dr. Salvador B. Gautier
Santo Domingo, República Dominicana
Rodolfo J. Galindo, MD, FACE
Assistant Professor of Medicine
Emory University School of Medicine
Principal Investigator, Center for Diabetes and Metabolism Research
Emory University Hospital Midtown
Medical Chair, Hospital Diabetes Taskforce
Emory Healthcare System
Accreditation and Credit Designation Statements
The University of Texas Southwestern Medical Center at Dallas is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Available Credit
- 2.00 AMA
- 2.00 Attendance
Price
Certificate
select the "Take Course" button to complete the course evaluation and to retrieve your certificate.
If you do not see the "Take Course" button, login to your EthosCE account or create an account using the email address used during the course registration or activity sign-in*. A profile can be created at the following link:
https://cme.utsouthwestern.edu/user/register
In order to access the course to retrieve a CME certificate the email provided at activity sign-in* must match the email in your EthosCE profile. If you provided an email different from your EthosCE profile please contact the CME office at [email protected]. If you have not already created a profile in EthosCE, please create one using the same email provided during the course registration or activity sign-in*.
*Course administrators may have retrieved the email address from the course registration, the organization directory or during the course/activity sign-in.
Certificado
seleccione el botón "Take Course" para completar la evaluación del curso y recuperar su certificado.
Si no ve el botón "Take Course", inicie sesión en su cuenta EthosCE o cree una cuenta con la dirección de correo electrónico utilizada durante el registro del curso o el inicio de sesión de actividad*. Se puede crear un perfil en el siguiente enlace:
https://cme.utsouthwestern.edu/user/register
Para acceder al curso para recuperar un certificado CME, el correo electrónico proporcionado en el inicio de sesión de actividad debe coincidir con el correo electrónico en su perfil EthosCE. Si proporcionó un correo electrónico diferente de su perfil EthosCE, comuníquese con la oficina de CME al [email protected]. Si aún no ha creado un perfil en EthosCE, cree uno utilizando el mismo correo electrónico proporcionado durante el registro del curso o el inicio de sesión de actividad*.
*Los administradores del curso pueden haber recuperado la dirección de correo electrónico del registro del curso, el directorio de la organización o durante el inicio de sesión del curso/actividad.